$TARA Cashflow Statement | Understand Stock

$TARA

$2.35 +$0.02 (0.86%) Close

$TARA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Loss on impairment of goodwill
Stock-based compensation
Operating lease right-of-use asset
Depreciation
Realized loss (gain) on redemption of marketable debt securities
Amortization of premium (Accretion of discount) on marketable debt securities

Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Operating lease liabilities
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of marketable debt securities
Proceeds from maturity and redemption of marketable debt securities
Purchase of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Repurchase of shares in connection with settlement of RSUs
Proceeds from December 2024 Public Offering, net of offering costs of $6,051
Proceeds from private placement, net of offering costs of $3,034
Proceeds from exercise of Underwriters’ Option in December 2024 Public Offering, net of offering costs of $214
Offering costs paid in connection with the December 2024 Public Offering
Proceeds from exercise of Warrants
Common Warrants
Pre-Funded Warrants
Total proceeds from exercise of Warrants
Proceeds from December 2025 Public Offering, net of offering costs of $5,286
Proceeds from exercise of stock options
Taxes paid related to net share settlement of restricted stock units
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash - beginning of year
Cash and cash equivalents and restricted cash - end of year
Supplemental disclosure of non-cash investing and financing activities:
Proceeds from public offering – offering costs incurred but not paid

Comments